Sumitomo Pharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	44,310	23,116	29,047	143,478	202,984
Cash & Short-Term Investments	44,310	23,116	29,047	143,478	202,984
Cash Growth	91.69%	-20.42%	-79.75%	-29.32%	4.79%
Accounts Receivable	131,414	74,840	81,023	95,908	151,407
Other Receivables	3,273	2,886	16,216	2,722	93
Receivables	134,687	77,726	97,239	98,630	151,500
Inventory	85,414	94,222	115,350	94,405	99,021
Other Current Assets	14,841	58,104	27,933	45,347	46,016
Total Current Assets	279,252	253,168	269,569	381,860	499,521
Property, Plant & Equipment	44,231	46,648	57,895	58,909	64,091
Long-Term Investments	36,400	72,339	182,368	144,399	127,909
Goodwill	211,098	197,406	199,783	209,415	195,144
Other Intangible Assets	160,474	172,509	195,652	329,314	398,692
Long-Term Deferred Tax Assets	421	534	2,239	10,845	22,650
Other Long-Term Assets	72,695	-	-	-	-
Total Assets	804,571	742,604	907,506	1,134,742	1,308,007
Accounts Payable	56,698	38,544	67,720	52,141	46,183
Short-Term Debt	-	42,440	174,588	90,588	5,025
Current Portion of Long-Term Debt	38,130	4,000	110,929	-	20,060
Current Portion of Leases	-	3,354	3,781	4,660	5,463
Current Income Taxes Payable	1,120	1,577	1,348	24,053	7,583
Other Current Liabilities	175,552	147,224	157,108	199,446	194,059
Total Current Liabilities	271,500	237,139	515,474	370,888	278,373
Long-Term Debt	179,056	258,982	133,367	244,128	243,963
Long-Term Leases	-	5,470	5,199	6,996	10,033
Pension & Post-Retirement Benefits	5,663	6,534	11,150	5,008	11,461
Long-Term Deferred Tax Liabilities	15,836	26,550	38,211	36,505	26,550
Other Long-Term Liabilities	40,049	38,450	47,969	64,435	64,058
Total Liabilities	512,104	573,125	751,370	727,960	634,438
Common Stock	22,400	22,400	22,400	22,400	22,400
Additional Paid-In Capital	-	-	-	-	16,725
Retained Earnings	158,981	46,784	-22,665	280,999	514,210
Treasury Stock	-684	-682	-682	-682	-681
Comprehensive Income & Other	111,770	100,977	157,010	104,032	55,234
Total Common Equity	292,467	169,479	156,063	406,749	607,888
Minority Interest	-	-	73	33	65,681
Shareholders' Equity	292,467	169,479	156,136	406,782	673,569
Total Liabilities & Equity	804,571	742,604	907,506	1,134,742	1,308,007
Total Debt	217,186	314,246	427,864	346,372	284,544
Net Cash (Debt)	-172,876	-291,130	-398,817	-202,894	-81,560
Net Cash Per Share	-435.14	-732.79	-1003.84	-510.69	-205.29
Filing Date Shares Outstanding	397.29	397.29	397.29	397.29	397.29
Total Common Shares Outstanding	397.29	397.29	397.29	397.29	397.29
Working Capital	7,752	16,029	-245,905	10,972	221,148
Book Value Per Share	736.16	426.59	392.82	1023.80	1530.08
Tangible Book Value	-79,105	-200,436	-239,372	-131,980	14,052
Tangible Book Value Per Share	-199.11	-504.51	-602.51	-332.20	35.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.